• No results found

Extended Release Capsules.

Development and Validation of an In Vitro and In Vivo Correlation Model in Rabbit for Topiramate Extended Release Capsules

Development and Validation of an In Vitro and In Vivo Correlation Model in Rabbit for Topiramate Extended Release Capsules

... 20% change in the fraction dissolution, it fails to show the bioequivalence to the marketed formulation. In conclusion, the present work established a preclinical IVIVC model for TPM extended release ...

9

FORMULATION AND DEVELOPMENT OF FLAVOXATE HYDROCHLORIDE EXTENDED RELEASE CAPSULES

FORMULATION AND DEVELOPMENT OF FLAVOXATE HYDROCHLORIDE EXTENDED RELEASE CAPSULES

... formulate extended release capsules of Flavoxate hydrochloride to reduce dosing frequency and decreasing the associated side ...The extended release capsules were formulated ...

8

Carbamazepine extended-release capsules in bipolar disorder

Carbamazepine extended-release capsules in bipolar disorder

... Carbamazepine extended-release capsules (CBZ-ERC) are a recent formulation of CBZ approved by the US Food and Drug Administration in 2004 for the treatment of acute manic and mixed episodes ...

10

“IN-VITRO
AND IN-VIVO DISSOLUTION OF
DIPYRIDAMOLE EXTENDED RELEASE CAPSULES” by Vellaian Karuppiah, Nagappan Kannappan and Rajappan Manavalan, India.

“IN-VITRO AND IN-VIVO DISSOLUTION OF DIPYRIDAMOLE EXTENDED RELEASE CAPSULES” by Vellaian Karuppiah, Nagappan Kannappan and Rajappan Manavalan, India.

... Effect on dissolution profile is observed on different agitation speed up to 200 RPM. At 200 RPM, the dissolution profile is low due to centripetal force during dissolution in basket. Results are presented in table 8. ...

5

 PHARMACOKINETIC AND BIOEQUIVALENCE COMPARISON BETWEEN EXTENDED RELEASE CAPSULES OF VENLAFAXINE HYDROCHLORIDE 150MG: AN OPEN LABEL, BALANCED, RANDOMIZED-SEQUENCE, SINGLE-DOSE, TWO-PERIOD CROSSOVER STUDY IN HEALTHY INDIAN MALE VOLUNTEERS

 PHARMACOKINETIC AND BIOEQUIVALENCE COMPARISON BETWEEN EXTENDED RELEASE CAPSULES OF VENLAFAXINE HYDROCHLORIDE 150MG: AN OPEN LABEL, BALANCED, RANDOMIZED-SEQUENCE, SINGLE-DOSE, TWO-PERIOD CROSSOVER STUDY IN HEALTHY INDIAN MALE VOLUNTEERS

... mg Extended Release Capsules in comparison with Effexor®-XR 150mg Extended Release Capsules after single dose administration under fed conditions in 20 healthy adult male ...

8

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

... Amantadine extended-release capsules (Gocovri™) is the first medication that received US Food and Drug Administration approval for the treat- ment of ...

9

FORMULATION AND EVALUATION OF TOLTERODINE TARTRATE EXTENDED RELEASE CAPSULES USING MULTIPARTICULATE DRUG DELIVERY SYSTEM

FORMULATION AND EVALUATION OF TOLTERODINE TARTRATE EXTENDED RELEASE CAPSULES USING MULTIPARTICULATE DRUG DELIVERY SYSTEM

... sustained release formulation, this can lead to “dose dumping” and result in dramatic side ...drug release, but also for the modified drug-release profiles they facilitate oral multiparticulate drug ...

7

Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting

Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting

... sulfate extended-release with his or her usual pain medication in the following four areas: pain relief during the whole day, ability to perform daily activities, ability to sleep, and side effects using a ...

12

Formulation and Evaluation of Galantamine Hydrobromide Extended Release Capsules

Formulation and Evaluation of Galantamine Hydrobromide Extended Release Capsules

... 37 Spray congealing is the process in which a drug is allowed to melt, disperse or dissolve in hot melts of gums, waxes or fatty acids, and is sprayed into an air chamber where the temperature is kept below the melting ...

121

Formulation and Evaluation of Methylphenidate Hydrochloride Extended Release Capsules

Formulation and Evaluation of Methylphenidate Hydrochloride Extended Release Capsules

... control release active ...modified release coatings to a variety of multi particulates and was also suitable for drug layering when the drug dose was in the low to medium ...

133

Development and in vitro Evaluation of Theophylline Loaded Matrix Tablets Prepared with Direct Compression

Development and in vitro Evaluation of Theophylline Loaded Matrix Tablets Prepared with Direct Compression

... sustained release matrix tablets of theophylline and to evaluate release properties and kinetic behaviour of these ...the release rate were ...drug release profiles. According the evaluation ...

7

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide

... hydrochloride extended release capsules (MS- sNT, EMBEDA ® ), indicated for moderate-to-severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of ...

7

Two Formulations of Venlafaxine are Bioequivalent when Administered as Open Capsule Mixed with Applesauce to Healthy Subjects

Two Formulations of Venlafaxine are Bioequivalent when Administered as Open Capsule Mixed with Applesauce to Healthy Subjects

... Venlafaxine is a unique antidepressant approved for treatment of various depressive disorders. A single dose, cross- over bioequivalence study was performed with two different formulations of venlafaxine 150 mg ...

7

FORMULATION AND EVALUATION OF DELAYED RELEASE ESOMEPRAZOLE PELLETS BY SUSPENSION LAYERING OF PELLETIZATION TECHNIQUE

FORMULATION AND EVALUATION OF DELAYED RELEASE ESOMEPRAZOLE PELLETS BY SUSPENSION LAYERING OF PELLETIZATION TECHNIQUE

... drug release and followed zero order drug with Higuchi release ...dissolution release profile complies with optimized formulation (C3) and ...dihydrate Capsules 40mg (C3) complies with the ...

14

Formulation and in vitro evaluation of bosentan osmatic controlled release tablets

Formulation and in vitro evaluation of bosentan osmatic controlled release tablets

... controlled release was studied. The release kinetics, dissolution rate, process variables such as hardness, weight variation are some of the factors found critical during the development based on the ...

9

Sono-Assembly of Highly Biocompatible Polysaccharide Capsules for Hydrophobic Drug Delivery

Sono-Assembly of Highly Biocompatible Polysaccharide Capsules for Hydrophobic Drug Delivery

... polysaccharide capsules is pursued in present ...assembling capsules of natural polysaccharides within few minutes during ...the capsules, as depicted in Scheme ...resulting capsules and ...

34

S. Jeganath*, K. Senthil kumaran, V. Ashlin viji, K. Sheeja devi

S. Jeganath*, K. Senthil kumaran, V. Ashlin viji, K. Sheeja devi

... the Extended Release Tablet of Divalproex Sodium using different viscosity concentration of hydrophilic polymer like Hydroxyl Propyl Methyl Cellulose K4M and Hydroxyl Propyl Methyl Cellulose K100M with ...

5

FORMULATION AND EVALUATION OF NITROFURANTOIN SUSTAINED RELEASE CAPSULE

FORMULATION AND EVALUATION OF NITROFURANTOIN SUSTAINED RELEASE CAPSULE

... Single unit capsules were formulated with various proportions of excipients. The drug nitrofurantoin and required quantity of each ingredient for each predetermined formulation were accurately weighed and blended ...

13

Formulation of Carbopol Capsules for Sustained Release of Losartan Potassium

Formulation of Carbopol Capsules for Sustained Release of Losartan Potassium

... drug release studies were carried out in USP type II dissolution apparatus containing 900mll of ...drug release over the period of 12 ...drug release from the capsules might have left large ...

6

ION EXCHANGE RESINS AND THEIR APPLICATIONS

ION EXCHANGE RESINS AND THEIR APPLICATIONS

... sustained- release systems because of their better drug-retaining properties and prevention of dose ...controlled release, transdermal, nasal, topical and taste masking 2 ...controlled release of ...

9

Show all 10000 documents...

Related subjects